SEC FORM
3
SEC Form 3
FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
OMB APPROVAL |
OMB Number: |
3235-0104 |
Estimated average burden |
hours per response: |
0.5 |
|
|
1. Name and Address of Reporting Person*
C/O MILLENNIUM MANAGEMENT, L.L.C. |
666 FIFTH AVENUE, 8TH FLOOR |
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 08/03/2007
|
3. Issuer Name and Ticker or Trading Symbol
HEALTHCARE ACQUISITION CORP
[ HAQ ]
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
Director |
X |
10% Owner |
|
Officer (give title below) |
|
Other (specify below) |
|
|
5. If Amendment, Date of Original Filed
(Month/Day/Year)
|
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Form filed by One Reporting Person |
X |
Form filed by More than One Reporting Person |
|
Table I - Non-Derivative Securities Beneficially Owned |
1. Title of Security (Instr.
4)
|
2.
Amount of Securities Beneficially Owned (Instr.
4)
|
3. Ownership Form: Direct (D) or Indirect (I) (Instr.
5)
|
4. Nature of Indirect Beneficial Ownership (Instr.
5)
|
Common stock, par value $0.001 (the "Common Stock") |
1,200,000 |
D
|
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivative Security (Instr.
4)
|
2. Date Exercisable and Expiration Date
(Month/Day/Year) |
3. Title and Amount of Securities Underlying Derivative Security (Instr.
4)
|
4. Conversion or Exercise Price of Derivative Security
|
5. Ownership Form: Direct (D) or Indirect (I) (Instr.
5)
|
6. Nature of Indirect Beneficial Ownership (Instr.
5)
|
Date Exercisable |
Expiration Date |
Title |
Amount or Number of Shares |
Warrants |
08/03/2007 |
07/27/2009 |
Common Stock |
457,610
|
6 |
D
|
|
1. Name and Address of Reporting Person*
C/O MILLENNIUM MANAGEMENT, L.L.C. |
666 FIFTH AVENUE, 8TH FLOOR |
(Street)
|
1. Name and Address of Reporting Person*
(Street)
|
1. Name and Address of Reporting Person*
C/O MILLENNIUM MANAGEMENT, L.L.C. |
666 FIFTH AVENUE, 8TH FLOOR |
(Street)
|
Explanation of Responses: |
|
MILLENCO, L.L.C., By: /s/ Mark Meskin, Chief Executive Officer |
08/06/2007 |
|
** Signature of Reporting Person |
Date |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. |
* If the form is filed by more than one reporting person,
see
Instruction
5
(b)(v). |
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |
Joint Filer Information
NAME: Millennium Management, L.L.C.
ADDRESS: 666 Fifth Avenue, 8th Floor
DESIGNATED FILER: Millenco, L.L.C.
ISSUER AND TICKER SYMBOL: Healthcare Acquisition Corp. (HAQ)
DATE OF EVENT REQUIRING STATEMENT: August 3, 2007
SIGNATURE:
By: /s/ David Nolan
------------------------
Name: David Nolan
Title: Co-President
Joint Filer Information
NAME: Israel A. Englander
ADDRESS: c/o Millennium Management, L.L.C.
666 Fifth Avenue, 8th Floor
New York, NY 10103
DESIGNATED FILER: Millenco, L.L.C.
ISSUER AND TICKER SYMBOL: Healthcare Acquisition Corp. (HAQ)
DATE OF EVENT REQUIRING STATEMENT: August 3, 2007
SIGNATURE:
Israel A. Englander
by David Nolan pursuant to Power of Attorney filed with the SEC on June 6, 2005
/s/ David Nolan
- ----------------------